Knisely A S
Department of Pathology, Division of Surgical Pathology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.
Pediatr Dev Pathol. 2000 Mar-Apr;3(2):113-25. doi: 10.1007/s100240050016.
Progressive familial intrahepatic cholestasis (PFIC), originally described as "Byler disease" in an Amish kindred, has been distinguished from other forms of cholestatic liver disease in childhood by clinical findings, clinical-laboratory observations, and morphologic studies in biopsy, hepatectomy, and autopsy specimens. Correlation with genetic analyses has permitted both more precise definition of PFIC and distinctions within PFIC. Two types of PFIC now are recognized: PFIC-1, resulting from mutations in a gene called FIC1 (familial intrahepatic cholestasis, type 1), and PFIC-2, resulting from mutations in a gene called BSEP (bile salt export pump). Other forms of PFIC may yet be identified. The roles of FIC1 and BSEP in the secretion of bile acids into bile and in the post-secretory modification of bile are under study.
进行性家族性肝内胆汁淤积症(PFIC)最初在一个阿米什家族中被描述为“比勒氏病”,通过临床发现、临床实验室观察以及活检、肝切除和尸检标本的形态学研究,已与儿童期其他形式的胆汁淤积性肝病区分开来。与基因分析的相关性使得对PFIC有了更精确的定义,并能区分PFIC的不同类型。目前已识别出两种类型的PFIC:PFIC-1,由一种名为FIC1(家族性肝内胆汁淤积症1型)的基因突变引起;PFIC-2,由一种名为BSEP(胆盐输出泵)的基因突变引起。其他形式的PFIC可能仍有待发现。FIC1和BSEP在胆汁酸分泌到胆汁以及胆汁分泌后修饰中的作用正在研究中。